Omnipod 5 Automated Insulin Delivery System: Facts vs Fake News - Part 1

Hosted by Nancy Hanna and Dena Gottesman

Leslie Barrett MS, RD, CDCES is an employee of Insulet Corporation. The views and opinions expressed are her own.

Nancy Hanna RN, BSN, CDCES and Dena Gottesman MS, RD, CDCES are joined by Leslie Barrett MS, RD, CDCES to clear up common misconceptions about the Omnipod® 5 Automated Insulin Delivery System. Leslie has been working on Omnipod 5 since the development from user experience and design to clinical trial site training and support. In part 1 of this fact from fake news episode she will share more details on the Omnipod 5 algorithm and best practices for everyday use and optimization.

Time stamps

7:08 – What are the requirements for entering Automated Mode?
19:27 – What are the considerations for transitioning from different therapies?
23:39 – How often should users deliver correction boluses?
27:51 – What are the adjustable settings for Omnipod 5, and what impacts algorithm behavior?

 

See more episodes
This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution.

Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.

The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older & type 2 diabetes in persons aged 18 years and older. The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with NovoLog®, Humalog®, and Admelog®. Refer to the Omnipod 5 Automated Insulin Delivery System User Guide and www.omnipod.com/safety for complete safety information including indications, contraindications, warnings, cautions, and instructions. Warning: DO NOT use SmartAdjust technology for individuals under 2 years of age or use less than 5 U of insulin per day. DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.